Amarin Corp Plc (AMRN)

[MedResCollab]

Well wait—you helped make my point. The numerous failed omega-3 studies used prescription ethyl ester omega-3s (Lovaza). Is that a supplement, or a drug? You think the studies failed because you think it takes 4 g/d EPA only to reduce ASCVD risk in at-risk subjects, yes? Not because Lovaza was a supplement and not a drug.

EPA is EPA is EPA. If you believe REDUCE-IT, you believe above a certain threshold of EPA absorption (perhaps absent DHA, etc) lowers your risk of ASCVD. So, take OmegaVia EPA 500, and get that EPA. Get even more than Vascepa will give you, and get it without the need to also take the pills with a high fat meal every single time, and without the potential organ damage from years of ingesting fatty acid ethyl esters.

This is easy. It’s not hard. It’s a supplement. It’s a nutrient, that you can supplement your diet with. It’s not even a debatable point.

Regards,
-MRC